The estimated Net Worth of Karen L Burton is at least $3.03 Миллион dollars as of 14 May 2024. Ms Burton owns over 3,000 units of Steris Plc stock worth over $909,904 and over the last 8 years she sold STE stock worth over $2,123,184.
Ms has made over 12 trades of the Steris Plc stock since 2017, according to the Form 4 filled with the SEC. Most recently she sold 3,000 units of STE stock worth $707,850 on 14 May 2024.
The largest trade she's ever made was exercising 7,500 units of Steris Plc stock on 4 June 2019 worth over $247,950. On average, Ms trades about 1,108 units every 76 days since 2017. As of 14 May 2024 she still owns at least 3,759 units of Steris Plc stock.
You can see the complete history of Ms Burton stock trades at the bottom of the page.
Karen L. Burton is the Chief Accounting Officer, VP & Controller at Steris Plc.
Ms Burton is 53, she's been the Chief Accounting Officer и VP & Controller of Steris Plc since . There are 10 older and 10 younger executives at Steris Plc. The oldest executive at Steris Plc is David Lewis, 76, who is the Independent Director.
Karen's mailing address filed with the SEC is C/O 70 SIR JOHN ROGERSON'S QUAY, , DUBLIN, L2, 2.
Over the last 9 years, insiders at Steris Plc have traded over $157,726,045 worth of Steris Plc stock. The most active insiders traders include Richard Martin Steeves, Walter M Jr Rosebrough и John P Wareham. On average, Steris Plc executives and independent directors trade stock every 19 days with the average trade being worth of $3,374,074. The most recent stock trade was executed by Christopher S Holland on 8 August 2024, trading 473 units of STE stock currently worth $113,369.
steris is a leading provider of infection prevention and procedural surgical products and services, focused primarily on healthcare, pharmaceutical, research and medical device customers. our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. while the corporation was founded as innovative medical technologies in 1985 and renamed steris in 1987, our history dates back to 1894 with the founding of american sterilizer company, a long-time, global leading innovator of sterilization products. today, through a series of strategic acquisitions and continual innovation of new products, steris holds one of the broadest portfolios of products in the industry. it stands at the forefront of efforts to prevent infection and contamination in healthcare, pharmaceutical and medical device environments.
Steris Plc executives and other stock owners filed with the SEC include: